格隆汇4月11日丨基石药业-B(02616.HK)公告,于2025年4月11日,董事会决议根据首次公开发售后受限制股份奖励计划向95名受限制股份单位承授人授出合共675.7万份受限制股份单位。同日,董事会决议根据首次公开发售后雇员持股计划向95名购股权承授人授予合共1577万份购股权,购股权的行使价每股股份2.406港元。授出受限制股份单位及授出购股权的原因为激励受限制股份单位承授人及购股权承授人...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.